You are here: Industry Insights > Cannabis

News List

Could medical marijuana help grandma and grandpa with their ailments worldpharmanews
March 01, 2019
Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral sclerosis...
NanoSphere Signs Definitive Licensing Agreement in Oregon pharmafocusasia
February 22, 2019
NanoSphere Health Sciences Inc. is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure, LLC......
New study analyzes cost effectiveness of smoked cannabis to treat chronic neuropathic pain worldpharmanews
January 31, 2019
Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective.
Preparing samples of cannabis plant for THC/CBD analysis cphi-online
January 16, 2019
Porvair Sciences has created a solid, stable and strong microplate that can withstand the applied forces in bead-beaters while maintaining a standard ANSI/SLAS footprint and key dimensions.
Today's More Potent Pot Means Higher Odds for Dependence: Study drugs
December 18, 2018
Pot's increasing potency could make it more likely that toking will interfere with users' lives, a new study argues.Compared to pot of the 1990s, today's marijuana contains significantly higher levels of THC.....
UK opens doors to cannabis-based therapies via NHS pharmaphorum
December 17, 2018
Medical cannabis is available to certain patients across the UK for the first time from today.The groundbreaking decision was made so that .....
New Zealand moves towards legalising medical cannabis pharmaceutical-technology
December 12, 2018
New Zealand’s parliament has passed an amendment to the Misuse of Drugs Act 1975 that will allow terminally ill patients to possess and use cannabis....
Cannabis-based compound may reduce seizures in children with epilepsy worldpharmanews
December 06, 2018
Interest has been growing in the use of cannabinoids - the active chemicals in cannabis or marijuana - for the treatment of epilepsy in children.
Beckley Canopy Therapeutics raises £7.4m for cannabis R&D pharmaphorum
December 05, 2018
Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle opioid addiction.
GW launches cannabis-based epilepsy drug in US pharmaphorum
November 30, 2018
GW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare form of childhood epilepsy.

Previous page 1 2 3 4 5 6 Next page